Approval · Notice of Compliance 3881 · 1997
IPRATROPIUM: Notice of Compliance 3881
Issued December 11, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3881
- Date
- December 11, 1997
- Company
- Pharmel Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Bronchodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IPRATROPIUM | 02236934 | Cancelled Post Market |
| IPRATROPIUM | 02236935 | Cancelled Post Market |
| IPRATROPIUM | 02237134 | Cancelled Post Market |
| IPRATROPIUM | 02237135 | Cancelled Post Market |
Medicinal ingredients
- IPRATROPIUM BROMIDE 125 MCG per ML
- IPRATROPIUM BROMIDE 250 MCG per ML